Skip to content

Revolutionizing Implant Loading: Prospective Clinical Trial in Partially Edentulous Patients.

Pioneering Immediate loading in tissue and bone level implants- A prospective clinical trial across diverse patient profiles in partially edentulous ridges. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100391
Enrollment
20
Registered
2026-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E07- Disorders of thyroid gland Health Condition 2: I10- Essential (primary) hypertension Health Condition 3: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Immediate loading in bone level and tissue level implant: Bone and Tissue level implants will be placed in partially edentulous ridges particularly in medically compromised patients fol

Sponsors

Dr Sweta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA 1)Age : 18-75 years 2)Patient willing for procedure (the study is explained, including the procedure and followup for evaluation) 3)Partially edentulous patients indicated replacement with an implant. 4)Patient presents with controlled diabetes/hypertension 5)Implant site free from infection 6)Adequate mouth opening 7) Sufficient bone volume for placing implants 8)Implants should be placed at healed sites.

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA 1.Insufficient bone quality 2. Inadequate mouth opening 3. Heavy smokers 4. Chronic alcoholic 5. Presence of vital anatomical structures close to the implant site 6. Patient under immunosuppressive therapy or radiotherapy 7. Psychiatric disorders 8. Disorders to the implant site related to a history of radiation therapy to the head and neck, or bone augmentation. 9.Recent myocardial infarction or cerebrovascular accident, ongoing chemotherapy treatment, intravenous anti-angiogenic agents use 10.Untreated bleeding issues

Design outcomes

Primary

MeasureTime frame
Evaluation of radiological, biological, and prosthetic outcomes of immediate loading in tissue and bone level implants. 1. Width of keratinised gingiva 2. IOPA with grid and cbct to measure crestal bone loss 3. incidence, frequency, onset of screw looseningTimepoint: 1. width of keratinised gingiva will be assessed at 3rd month interval, 6th month interval and at the end of one year interval. 2.IOPA with Grid to measure crestal bone loss will be assessed at 3rd month ,6th month , and at the end of one year interval. 3.Incidence/ Frequency /onset of screw loosening at 3, 6 and 1 year interval

Secondary

MeasureTime frame
1.Crestal Bone Loss: Assessing the amount of crestal bone loss around the implants at various follow-up intervals. 2.Width of Keratinized Mucosa: Measuring the width of keratinized mucosa at the implant site, specifically at the mid-buccal aspect of each implant. 3.Incidence, Frequency & onset of screw loosening Timepoint: 1.3rd month interval, 6th month interval & at the end of one year interval. 2. at 3rd month ,6th month , & at the end of one year interval. 3.At 3rd,6th, & one year interval.

Countries

India

Contacts

Public ContactDr Anshul Trivedi

subharti dental college and hospital, swami vivekanand university, Meerut

dranshulmsaxena@gmail.com9012694104

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026